SecBot SecBot
SC 13G/A ·Filed Oct 16, 2026

MMED

MiniMed Group, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed10d 7h ago SEC0001999371-26-022971
Passive stake amendment
Actionable Insight • Neutral

Medtronic's complete exit via split-off removes a large overhang and simplifies MiniMed's shareholder base. Monitor for any subsequent insider or institutional filings that may signal new ownership dynamics post-separation.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+5d ⚠ clustered
MMED ▲ +4.89% at T+5d
NEUTRAL call +4.89% · α vs SPY +5.04% · entry $17.79 → $18.66
Next anchor: T+20d in 17d
Entry = T+0 close
Oct 16, 2026
via day close
T+1d
-1.69%
call -1.69% · α -2.02%
$17.49
settled 8d ago
T+5d
+4.89%
call +4.89% · α +5.04%
$18.66
settled 4d ago
T+20d
Pending
in 17d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Medtronic plc filed an amendment to its Schedule 13G reporting that it has ceased to beneficially own any shares of MiniMed Group, Inc. common stock following a split-off exchange offer completed on October 15, 2026, in which Medtronic exchanged approximately 90% of outstanding MiniMed shares for its own ordinary shares. Medtronic no longer holds more than 5% of MiniMed's common stock and has terminated its reporting obligation.

Key Financial Metrics

Stake
0%
Stake Value
$0.00
Investor
Medtronic plc

Key Facts

  • Medtronic completed a split-off exchange offer on October 15, 2026, exchanging approximately 90% of MiniMed's outstanding common stock for Medtronic ordinary shares.
  • Medtronic now holds 0 shares of MiniMed common stock (0.0% ownership).
  • This is an amendment to Schedule 13G reflecting Medtronic's exit from its prior >5% stake.
  • Medtronic has ceased to be a Schedule 13G reporting person with regard to MiniMed common stock.

Financial Impact

Medtronic disposed of approximately 90% of MiniMed's outstanding common stock via a split-off exchange. The exact value is not stated in the filing.

ownershipshare count

Risk Factors

  • The split-off may have been executed at a discount to fair value, potentially pressuring MiniMed's stock if the exchange was viewed as unfavorable.
  • Loss of Medtronic's strategic backing could reduce MiniMed's perceived creditworthiness or partnership opportunities.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001999371-26-022971
Document: 0001999371-26-022971-index.html0001999371-26-022971
Document: 0001999371-26-022971.txt0001999371-26-022971
22 reports for MMED
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for MMED — sortable, filterable
TypeNow
Oct 22, 2026
4d ago
SC 13G
NEUTRAL ★ 4/10
$18.34awaiting T+20—$18.66 (+1.74%)
Oct 16, 2026
10d ago
SC 13G/A
NEUTRAL ★ 4/10
$17.79awaiting T+20—$18.66 (+4.89%)
Oct 16, 2026
10d ago
8-K
NEUTRAL ★ 6/10
$17.49awaiting T+20—$18.66 (+6.69%)
Oct 6, 2026
21d ago
EFFECT
NEUTRAL ★ 3/10
$19.64awaiting T+20—$18.66 (−4.99%)
Oct 1, 2026
25d ago
3
NEUTRAL ★ 2/10
$19.70awaiting T+20—$18.66 (−5.28%)
Sep 14, 2026
6w ago
425
NEUTRAL ★ 4/10
$21.97 $18.80▼ −14.43%▼ −16.69%$18.66 (−15.07%)
Sep 14, 2026
6w ago
425
NEUTRAL ★ 4/10
$21.97 $18.80▼ −14.43%▼ −16.69%$18.66 (−15.07%)
Sep 14, 2026
6w ago
425
MIXED ★ 5/10
$21.97 $18.80▼ −14.43%▼ −16.69%$18.66 (−15.07%)
Sep 14, 2026
6w ago
425
NEUTRAL ★ 4/10
$21.97 $18.80▼ −14.43%▼ −16.69%$18.66 (−15.07%)
Sep 14, 2026
6w ago
425
NEUTRAL ★ 4/10
$21.97 $18.80▼ −14.43%▼ −16.69%$18.66 (−15.07%)
Showing 10 of 22

US Market Status

Market Closed — Opens in 9h 14m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 16, 2026